tetano
Editor, Senior Moderator
Diagn Microbiol Infect Dis
. 2021 Jun 6;101(3):115450.
doi: 10.1016/j.diagmicrobio.2021.115450. Online ahead of print.
The reliability of saliva for the detection of SARS-CoV-2 in symptomatic and asymptomatic patients: Insights on the diagnostic performance and utility for COVID-19 screening
Khaled J Alkhateeb[SUP] 1 [/SUP], Meredith N Cahill[SUP] 2 [/SUP], Adam S Ross[SUP] 3 [/SUP], Forest W Arnold[SUP] 2 [/SUP], James W Snyder[SUP] 4 [/SUP]
Affiliations
Abstract
Current literature has focused on testing saliva in symptomatic patients, and little information is available regarding saliva performance in asymptomatic severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection. We compared paired saliva and nasopharyngeal swabs (NPS) collected from 33 symptomatic and 12 asymptomatic known SARS-CoV-2-positive patients. Saliva had an overall sensitivity of 59%, a specificity of 95%, and a negative predictive value of 98%. Saliva demonstrated higher sensitivity in symptomatic (80%) vs. asymptomatic individuals (36%) (P = 0.006), and in high-risk (symptomatic, febrile and/or with comorbidities) (82%) vs. low-risk (asymptomatic, afebrile, and no comorbidities) (22%) patients (P = 0.0002). Cycle threshold (Ct) values in NPS specimens were higher in saliva-negative vs. saliva-positive cases (P = 0.02 and <0.001). Overall, these findings show that despite saliva's low sensitivity in asymptomatic SARS-CoV-2 infections, it can detect infections with lower Ct values and a potentially higher chance of viral transmission. Additional studies are warranted to fully evaluate saliva as a screening test for coronavirus disease-2019.
Keywords: Asymptomatic; COVID-19; Nasopharyngeal swab; SARS-CoV-2; Saliva; Screening.
. 2021 Jun 6;101(3):115450.
doi: 10.1016/j.diagmicrobio.2021.115450. Online ahead of print.
The reliability of saliva for the detection of SARS-CoV-2 in symptomatic and asymptomatic patients: Insights on the diagnostic performance and utility for COVID-19 screening
Khaled J Alkhateeb[SUP] 1 [/SUP], Meredith N Cahill[SUP] 2 [/SUP], Adam S Ross[SUP] 3 [/SUP], Forest W Arnold[SUP] 2 [/SUP], James W Snyder[SUP] 4 [/SUP]
Affiliations
- PMID: 34284319
- DOI: 10.1016/j.diagmicrobio.2021.115450
Abstract
Current literature has focused on testing saliva in symptomatic patients, and little information is available regarding saliva performance in asymptomatic severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection. We compared paired saliva and nasopharyngeal swabs (NPS) collected from 33 symptomatic and 12 asymptomatic known SARS-CoV-2-positive patients. Saliva had an overall sensitivity of 59%, a specificity of 95%, and a negative predictive value of 98%. Saliva demonstrated higher sensitivity in symptomatic (80%) vs. asymptomatic individuals (36%) (P = 0.006), and in high-risk (symptomatic, febrile and/or with comorbidities) (82%) vs. low-risk (asymptomatic, afebrile, and no comorbidities) (22%) patients (P = 0.0002). Cycle threshold (Ct) values in NPS specimens were higher in saliva-negative vs. saliva-positive cases (P = 0.02 and <0.001). Overall, these findings show that despite saliva's low sensitivity in asymptomatic SARS-CoV-2 infections, it can detect infections with lower Ct values and a potentially higher chance of viral transmission. Additional studies are warranted to fully evaluate saliva as a screening test for coronavirus disease-2019.
Keywords: Asymptomatic; COVID-19; Nasopharyngeal swab; SARS-CoV-2; Saliva; Screening.